Ajanta Pharma shares gain 5% after in-licensing agreement with Biocon for Semgalutide

December 24, 2025
Uncategorized

Biocon will supply semaglutide to Ajanta Pharma for exclusive marketing in 23 countries and semi-exclusive marketing in thee countries across Africa, Centra Asia and the Middle East.

Ajanta Pharma shares gain 5% after in-licensing agreement with Biocon for Semgalutide

Leave a ReplyCancel Reply

Torrent Pharma shares in focus after steady Q3; Street positive on JB merger benefits

Why are gold and silver trading volatile despite softer dollar

Lupin shares may see up to 16% upside post Q3, analysts say — should you buy?

Netflix and Amazon are among the most oversold stocks on Wall Street

Angel One, Groww shares in focus after RBI tightens capital market exposure norms